Differences in genomic instability between intestinal- and diffuse-type gastric cancer - PubMed (original) (raw)
Differences in genomic instability between intestinal- and diffuse-type gastric cancer
Matti Vauhkonen et al. Gastric Cancer. 2005.
Abstract
Background: Microsatellite instability (MSI) and loss of heterozygosity (LOH) are lesions in the genome found with different frequencies in gastric carcinomas (GCAs). Despite a great body of studies, no systematic approach to the detailed classification of MSI and LOH in the two major types of GCA has been published.
Methods: Thirty-seven advanced GCAs, 25 intestinal-type (IGCAs) and 12 diffuse-type (DGCAs), were assayed with 15 autosomal tetranucleotide markers on 14 chromosomal arms. The observed frequencies and types of microsatellite alterations allowed stratification into subgroups, i.e., high- and low-grade MSI (MSI-H, MSI-L) or microsatellite-stable (MSS), and high- or low-grade, or non-detectable LOH (LOH-H, LOH-L, LOH-N).
Results: Collectively, the markers detected MSI-H tumors with sensitivity equal to that of BAT-26 (a single marker highly specific for MSI-H). Likewise, the markers detected LOH at chromosomal arms 5q, 18q, and 21q with a sensitivity equal to markers used previously. Seven (19%) MSI-H and six (16%) LOH-H tumors were found, with a significant association (P = 0.027) with IGCA: 92% of MSI-H and LOH-H occurred in IGCA patients only. Conversely, in DGCA, a significantly higher prevalence of a stable (LOH-N/MSS) phenotype was found as compared with IGCA (75.1% vs 28.0%; P = 0.035). The MSI-L phenotype was found in 57.9% of non-MSI-H IGCA tumors and was associated significantly (P = 0.015) with LOH-H.
Conclusion: A clear difference in genomic instability between IGCA and DGCA was found. In IGCA, the MSI and LOH pathways were more commonly involved, whereas in DGCA, a stable phenotype was predominant. As a novel finding, MSI-L as a true phenomenon and its association with LOH was observed in IGCA.
Similar articles
- Genetic classification of intestinal-type and diffuse-type gastric cancers based on chromosomal loss and microsatellite instability.
Kim KM, Kwon MS, Hong SJ, Min KO, Seo EJ, Lee KY, Choi SW, Rhyu MG. Kim KM, et al. Virchows Arch. 2003 Oct;443(4):491-500. doi: 10.1007/s00428-003-0840-0. Epub 2003 Aug 15. Virchows Arch. 2003. PMID: 12920592 - Prognostic implications of microsatellite genotypes in gastric carcinoma.
Choi SW, Choi JR, Chung YJ, Kim KM, Rhyu MG. Choi SW, et al. Int J Cancer. 2000 Jul 20;89(4):378-83. doi: 10.1002/1097-0215(20000720)89:4<378::aid-ijc10>3.0.co;2-t. Int J Cancer. 2000. PMID: 10956413 - Chromosomal and microsatellite instability in sporadic gastric cancer.
Hiyama T, Tanaka S, Yoshihara M, Sasao S, Kose K, Shima H, Tuncel H, Ueno Y, Ito M, Kitadai Y, Yasui W, Haruma K, Chayama K. Hiyama T, et al. J Gastroenterol Hepatol. 2004 Jul;19(7):756-60. doi: 10.1111/j.1440-1746.2004.03369.x. J Gastroenterol Hepatol. 2004. PMID: 15209621 - Pathology and molecular biology of gastric cancer.
Vauhkonen M, Vauhkonen H, Sipponen P. Vauhkonen M, et al. Best Pract Res Clin Gastroenterol. 2006;20(4):651-74. doi: 10.1016/j.bpg.2006.03.016. Best Pract Res Clin Gastroenterol. 2006. PMID: 16997151 Review. - Microsatellite instability and gastric non-invasive neoplasia in a high risk population in Cesena, Italy.
Rugge M, Bersani G, Bertorelle R, Pennelli G, Russo VM, Farinati F, Bartolini D, Cassaro M, Alvisi V. Rugge M, et al. J Clin Pathol. 2005 Aug;58(8):805-10. doi: 10.1136/jcp.2004.025676. J Clin Pathol. 2005. PMID: 16049280 Free PMC article. Review.
Cited by
- Expression of anion exchanger 1 is associated with tumor progress in human gastric cancer.
Xu WQ, Song LJ, Liu Q, Zhao L, Zheng L, Yan ZW, Fu GH. Xu WQ, et al. J Cancer Res Clin Oncol. 2009 Oct;135(10):1323-30. doi: 10.1007/s00432-009-0573-9. Epub 2009 Mar 28. J Cancer Res Clin Oncol. 2009. PMID: 19330352 - Helicobacter pylori and EBV in gastric carcinomas: methylation status and microsatellite instability.
Ferrasi AC, Pinheiro NA, Rabenhorst SH, Caballero OL, Rodrigues MA, de Carvalho F, Leite CV, Ferreira MV, Barros MA, Pardini MI. Ferrasi AC, et al. World J Gastroenterol. 2010 Jan 21;16(3):312-9. doi: 10.3748/wjg.v16.i3.312. World J Gastroenterol. 2010. PMID: 20082476 Free PMC article. - Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study.
Gylling A, Abdel-Rahman WM, Juhola M, Nuorva K, Hautala E, Järvinen HJ, Mecklin JP, Aarnio M, Peltomäki P. Gylling A, et al. Gut. 2007 Jul;56(7):926-33. doi: 10.1136/gut.2006.114876. Epub 2007 Jan 31. Gut. 2007. PMID: 17267619 Free PMC article. - Integrated assessment of PD-L1 expression and molecular classification facilitates therapy selection and prognosis prediction in gastric cancer.
Sun Y, Yu W, Guan W, Cai L, Qiao M, Zheng L, Jiang R, Wang R, Wang L. Sun Y, et al. Cancer Manag Res. 2019 Jul 10;11:6397-6410. doi: 10.2147/CMAR.S206189. eCollection 2019. Cancer Manag Res. 2019. PMID: 31372044 Free PMC article. - Genetic differences stratified by PCR-based microsatellite analysis in gastric intramucosal neoplasia.
Sugai T, Sugimoto R, Habano W, Endoh M, Eizuka M, Tsuchida K, Yamamoto E, Kawasaki K, Yanai S, Matsumoto T, Suzuki H. Sugai T, et al. Gastric Cancer. 2017 Mar;20(2):286-296. doi: 10.1007/s10120-016-0616-2. Epub 2016 May 28. Gastric Cancer. 2017. PMID: 27236438
References
- J Pathol. 2003 Nov;201(3):389-94 - PubMed
- Gastric Cancer. 1998 Dec;1(1):31-50 - PubMed
- Int J Cancer. 1993 Oct 21;55(4):598-603 - PubMed
- IARC Sci Publ. 2004;(157):327-49 - PubMed
- Cancer Res. 1997 Jan 15;57(2):300-3 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials